East Coast firms add experienced attorneys and specialists

Three East Coast law firms have added experienced attorneys and specialists to their existing health care and life sciences practice groups, with two welcoming partners to their offices and one adding a former government official to its team.

W. Andrew Gantt III has returned to Venable LLP, the firm where he began his legal career, as a partner and co-chair of the firm’s Healthcare practice. He draws on more than 20 years of legal experience to represent health care and life sciences companies, health plans, providers, and suppliers, along with manufacturers and health care information technology, information services, and digital health companies in corporate and regulatory matters. He also advises investors and other financial groups with respect to regulatory issues related to mergers and acquisitions and other matters. Gantt has received national recognition for providing advice regarding Health Insurance Portability and Accountability Act (HIPAA) (P.L. 104-191) compliance and other data, security, and digital health regulatory issues. Gantt looks forward to his work, noting, “Early on, Venable ignited the passion I have today for my law practice, and whether the Affordable Care Act continues in its current form or sees a dramatic overhaul, change is on the horizon for the healthcare industry.” Gant is based in the Baltimore and Washington D.C. offices, but will spend time in San Francisco.

Goodwin Procter LLP welcomes Catherine McCarty as a partner in the firm’s Technology and Life Sciences Group. An intellectual property (IP) specialist, McCarty focuses on IP relating to pharmaceuticals and general chemistry matters, including small molecule drugs, salt forms, solid forms and chemical processes. McCarty aids life sciences companies in protecting their property and advises organizations that invest in pharmaceutical and life sciences and technologies. She works on a variety of projects, including designing and managing worldwide patent estates on drug candidates. She practices in the firm’s Boston office.

Arent Fox LLP has added former Deputy Under Secretary of Food Safety at the U.S. Department of Agriculture (USDA) Brian Ronholm to its Food, Drug, Medical Device & Agriculture Practice as Senior Director of Regulatory Policy. FDA practice leader James R. Ravitz lauded Ronholm’s addition, noting, “As a former senior agency official, he is in a unique position to advise food industry clients and he solidifies our ability to provide comprehensive counseling on food safety matters before the FDA and USDA.” Concentrating on food safety regulation and policy, Ronholm provides clients with strategic advice on navigating regulatory challenges. Ronholm works in the firm’s D.C. office.